The European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) have published new guidance to prevent blood-borne viruses in prison settings. People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV, often linked to a history of injecting drug use. In addition, incarceration can result in a higher risk of transmission of communicable diseases, due to factors such as overcrowding, poor healthcare facilities and delayed diagnosis.
The ECDC–EMCDDA Guidance is based on a series of comprehensive reviews and analyses of the published literature and consultation with a scientific expert panel. It identifies the most (cost-)effective approaches with the aim to interrupt transmission in, and between, prison settings as well as the community.
Source: ECDC, 23 July 2018